MAUDE Adverse Event Report: ENCORE MEDICAL L.P. FMP LINER; LINER, ACETABULAR, FMP CONSTRAINED 28XMP8

Model Number	436-28-008
Health Effect - Clinical Code	Joint Dislocation (2374)
Date of Event	07/18/2018
Type of Reportable Event	Serious Injury
Event or Problem Description
Third revision surgery - due to multiple dislocations.The surgeon removed a djo product but used another vendor for revision surgery.
Additional Manufacturer Narrative
The reason for this revision surgery was due to a dislocation.The in-vivo length of patient service for the implant was 11.2 months.The previous surgery and the revision detailed in this investigation occurred 8.4 months apart.There is no information in this complaint about any patient injuries, activities, or accidents that may have contributed to the need for this revision surgery.There are no reported pre-existing patient health conditions.The healthcare professional indicated there was a serious risk to the patient.There was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhr) shows that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to the event.The device was within its expiration date at the time of use during the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was a revision surgery due to dislocation.There were no findings during this investigation that indicate that the reported device was the source or had a direct connection with the event.There are many factors that may contribute to the event that are outside the control of djo surgical such as: inadequate soft tissue support, excessive range of motion, patient bone deterioration, patient activities or trauma.Inventory containment is not required as there are no indications of a product or process issue affecting implant safety or effectiveness.

• Brand Name: FMP LINER
• Common Device Name: LINER, ACETABULAR, FMP CONSTRAINED 28XMP8
• Manufacturer (Section D): ENCORE MEDICAL L.P.; 9800 metric blvd; austin TX 78758 5445
• MDR Report Key: 7733061
• Report Number: 1644408-2018-00718
• Device Sequence Number: 11140724
• Product Code: KWZ
• UDI-Device Identifier: 00888912085717
• UDI-Public: (01)00888912085717
• Combination Product (Y/N): N
• Initial Reporter State: AZ
• Initial Reporter Country: US
• PMA/510(K) Number: K023794
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2017
• Device Explanted Year: 2018
• Reporter Type: Manufacturer
• Report Source: company representative
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 08/09/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 05/10/2021
• Device Model Number: 436-28-008
• Device Catalogue Number: 436-28-008
• Device Lot Number: 500C1007
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 07/18/2018
• Supplement Date Received by Manufacturer: 08/09/2016
• Initial Report FDA Received Date: 07/30/2018
• Supplement Report FDA Received Date: 08/09/2018
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: 010-55-030, LOT 007A1058; 400-05-004, LOT 887B1034; 425-31-008, LOT 098P1003; 430-98-054, LOT 590G1007; 436-28-000, LOT 496C1070; 497-28-105, LOT 632C1042; 010-55-030, LOT 007A1058; 400-05-004, LOT 887B1034; 425-31-008, LOT 098P1003; 430-98-054, LOT 590G1007; 436-28-000, LOT 496C1070; 497-28-105, LOT 632C1042
• Outcome Attributed to Adverse Event: Other; Required Intervention
• Patient Age: 89 YR